Who depends on Alexion
Alexion appears in 2 disclosed customer relationships between 2016 and 2020.
Get an email when Alexion's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on Alexion
Listed companies whose annual report names Alexion as a customer worth 10% or more of their revenue. If Alexion cuts orders or switches supplier, these are the companies that feel it.
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| ModernaMRNA | 36% | last FY 2017 | 2 years | FY 2017 · filed 27 Feb 2020 |
| Halozyme TherapeuticsHALO | 1% | last FY 2019 | 3 years | FY 2019 · filed 24 Feb 2020 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API